These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 28832656)

  • 1. Involvement of insulin resistance in D-galactose-induced age-related dementia in rats: Protective role of metformin and saxagliptin.
    Kenawy S; Hegazy R; Hassan A; El-Shenawy S; Gomaa N; Zaki H; Attia A
    PLoS One; 2017; 12(8):e0183565. PubMed ID: 28832656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. d-galactose and aluminium chloride induced rat model with cognitive impairments.
    Chiroma SM; Mohd Moklas MA; Mat Taib CN; Baharuldin MTH; Amon Z
    Biomed Pharmacother; 2018 Jul; 103():1602-1608. PubMed ID: 29864948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term therapy with combination dipeptidyl peptidase-4 inhibitor saxagliptin/metformin extended release (XR) is superior to saxagliptin or metformin XR monotherapy in prediabetic women with polycystic ovary syndrome: a single-blind, randomized, pilot study.
    Elkind-Hirsch KE; Paterson MS; Seidemann EL; Gutowski HC
    Fertil Steril; 2017 Jan; 107(1):253-260.e1. PubMed ID: 28228317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of tetrahydropalmatine against d-galactose induced memory impairment in rat.
    Qu Z; Zhang J; Yang H; Huo L; Gao J; Chen H; Gao W
    Physiol Behav; 2016 Feb; 154():114-25. PubMed ID: 26592138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of antidiabetic agents on Alzheimer's disease biomarkers in experimentally induced hyperglycemic rat model by streptozocin.
    Ali SK; Ali RH
    PLoS One; 2022; 17(7):e0271138. PubMed ID: 35802659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of kinetin against aluminum chloride and D-galactose induced cognitive impairment and oxidative damage in mouse.
    Wei Y; Liu D; Zheng Y; Li H; Hao C; Ouyang W
    Brain Res Bull; 2017 Sep; 134():262-272. PubMed ID: 28867383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Therapeutic Effect of Single/Combined Administration of Saxagliptin, Metformin and Intranasal Insulin on Dexamethasone Induced Insulin Resistance in Albino Wistar Rat Model.
    Oche J; Olorundare O; Afolabi S; Ologe M; Njan A; Akanbi O
    Niger J Physiol Sci; 2023 Jun; 38(1):37-46. PubMed ID: 38243349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of saxagliptin added to sub-maximal doses of metformin compared with uptitration of metformin in type 2 diabetes: the PROMPT study.
    Hermans MP; Delibasi T; Farmer I; Lohm L; Maheux P; Piatti P; Malvolti E; Jörgens S; Charbonnel B
    Curr Med Res Opin; 2012 Oct; 28(10):1635-45. PubMed ID: 23020253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saponins from Panax japonicus attenuate D-galactose-induced cognitive impairment through its anti-oxidative and anti-apoptotic effects in rats.
    Wang T; Di G; Yang L; Dun Y; Sun Z; Wan J; Peng B; Liu C; Xiong G; Zhang C; Yuan D
    J Pharm Pharmacol; 2015 Sep; 67(9):1284-96. PubMed ID: 25892055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro antiglycating effect and in vivo neuroprotective activity of Trigonelline in d-galactose induced cognitive impairment.
    Chowdhury AA; Gawali NB; Bulani VD; Kothavade PS; Mestry SN; Deshpande PS; Juvekar AR
    Pharmacol Rep; 2018 Apr; 70(2):372-377. PubMed ID: 29477946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anthocyanins Reversed D-Galactose-Induced Oxidative Stress and Neuroinflammation Mediated Cognitive Impairment in Adult Rats.
    Rehman SU; Shah SA; Ali T; Chung JI; Kim MO
    Mol Neurobiol; 2017 Jan; 54(1):255-271. PubMed ID: 26738855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained 52-week efficacy and safety of triple therapy with dapagliflozin plus saxagliptin versus dual therapy with sitagliptin added to metformin in patients with uncontrolled type 2 diabetes.
    Handelsman Y; Mathieu C; Del Prato S; Johnsson E; Kurlyandskaya R; Iqbal N; Garcia-Sanchez R; Rosenstock J
    Diabetes Obes Metab; 2019 Apr; 21(4):883-892. PubMed ID: 30499237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carnosine Treatment Diminished Oxidative Stress and Glycation Products in Serum and Tissues of D-Galactose-Treated Rats.
    Aydin F; Kalaz EB; Kucukgergin C; Coban J; Dogru-Abbasoglu S; Uysal M
    Curr Aging Sci; 2018; 11(1):10-15. PubMed ID: 28676006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of dapagliflozin plus saxagliptin versus insulin glargine over 52 weeks as add-on to metformin with or without sulphonylurea in patients with type 2 diabetes: A randomized, parallel-design, open-label, Phase 3 trial.
    Vilsbøll T; Ekholm E; Johnsson E; Garcia-Sanchez R; Dronamraju N; Jabbour SA; Lind M
    Diabetes Obes Metab; 2020 Jun; 22(6):957-968. PubMed ID: 32003150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of glycemic control and β-cell function in new onset T2DM patients with PCOS of metformin and saxagliptin monotherapy or combination treatment.
    Tao T; Wu P; Wang Y; Liu W
    BMC Endocr Disord; 2018 Feb; 18(1):14. PubMed ID: 29482528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effects of dapagliflozin plus saxagliptin versus glimepiride on a background of metformin in patients with type 2 diabetes: Results of a 104-week extension to a 52-week randomized, phase 3 study and liver fat MRI substudy.
    Frías JP; Maaske J; Suchower L; Johansson L; Hockings PD; Iqbal N; Wilding JPH
    Diabetes Obes Metab; 2022 Jan; 24(1):61-71. PubMed ID: 34514692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effect of saxagliptin and glimepiride with a composite endpoint of adequate glycaemic control without hypoglycaemia and without weight gain in patients uncontrolled with metformin therapy: Results from the SPECIFY study, a 48-week, multi-centre, randomized, controlled trial.
    Gu T; Ma J; Zhang Q; Zhu L; Zhang H; Xu L; Cheng J; Shi B; Li D; Shao J; Sun Z; Zhong S; Bi Y; Zhu D
    Diabetes Obes Metab; 2019 Apr; 21(4):939-948. PubMed ID: 30520221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candesartan protects against d-galactose induced - Neurotoxicity and memory deficit via modulation of autophagy and oxidative stress.
    Khedr NF; Werida RH; Abo-Saif MA
    Toxicol Appl Pharmacol; 2022 Jan; 435():115827. PubMed ID: 34906534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Saxagliptin efficacy and safety in patients with type 2 diabetes mellitus stratified by cardiovascular disease history and cardiovascular risk factors: analysis of 3 clinical trials.
    Cook W; Minervini G; Bryzinski B; Hirshberg B
    Postgrad Med; 2014 Oct; 126(6):19-32. PubMed ID: 25414932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual add-on therapy in type 2 diabetes poorly controlled with metformin monotherapy: a randomized double-blind trial of saxagliptin plus dapagliflozin addition versus single addition of saxagliptin or dapagliflozin to metformin.
    Rosenstock J; Hansen L; Zee P; Li Y; Cook W; Hirshberg B; Iqbal N
    Diabetes Care; 2015 Mar; 38(3):376-83. PubMed ID: 25352655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.